Peter Lea, Ph.D.
Peter Lea, Ph.D., the founder of SQI Diagnostics, invented and patented the core technology underpinning SQI Diagnostics multiplexing microarray technology targeted for autoimmune disease testing in reference laboratories. Peter lead the commercializing of the world's first microarray diagnostic platform incorporating automation, calibration and normalization in each test well plus multiplexing at the antigen and uniquely at the antibody subclass, a world first, something that SQI calls Ig_plex.
Peter has a unique blend of academic accomplishments and industry experience that have been instrumental to his scientific leadership of the SQI technology.
Dr. Lea has been instrumental in managing the IP portfolio for SQI and has four patents issued and 15 patents pending to support the complexity and uniqueness of the SQI Diagnostics multiplexing microarray system.